Skip to main content
رجوع
Watch Compare

CTT PHARMACEUTICAL HOLDINGS, INC.

جودة البيانات: 83%
CTTH
OTC Energy Metal Mining
KWD 0.07
KWD 0.00 (0.00%)
القيمة السوقية: 3.82 M
السعر
KWD 0.07
القيمة السوقية
3.82 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Earnings grew 106.26% over the past year
Negative free cash flow of -131,174.0

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)106.26%
FCF Growth (3Y)N/A

الجودة

Return on Equity
-89.30%
أقل من متوسط القطاع (3.74%)
ROIC-72.02%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

التقييم

PE (TTM)
-4.97
أقل من متوسط القطاع (3.38)
P/B Ratio5.18
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Energy (547 نظير)
المقياس السهم وسيط القطاع
P/E -5.0 3.4
P/B 5.2 2.1
ROE % -89.3 3.7
Net Margin % — 4.9
Rev Growth 5Y % — 9.4
D/E — 0.5

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

لا تتوفر تقديرات مستقبلية

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) 106.26% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -770,159.0
ROE -89.30% ROA -73.16%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -131,174.0
ROIC -72.02% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value 738,078
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.97 Forward P/E N/A
P/B Ratio 5.18 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3.43%
Market Cap 3.82 M Enterprise Value 3.79 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 17.03%
SBC-Adj. FCF -270,398 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2014 FY2013 FY2012 FY2011
Revenue — — — —
Net Income 227,838.0 110,464.0 -1.00 M 3.74 M
EPS (Diluted) — 0.01 -0.11 0.40
Gross Profit — — — —
Operating Income -672,162.0 92,201.0 -1.19 M -757,935.0
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A — — — 0.0
Interest Expense — — — —
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2014 FY2013 FY2012 FY2011
Total Assets 1.66 M 6,252.0 203,079.0 4.18 M
Total Liabilities 1.08 M 249,378.0 589,413.0 3.73 M
Shareholders' Equity 586,630.0 -243,126.0 -386,334.0 456,450.0
Total Debt — — — —
Cash & Equivalents 81,179.0 823.0 12,091.0 569,378.0
Current Assets 1.05 M 6,252.0 203,079.0 750,734.0
Current Liabilities — 249,378.0 589,413.0 3.73 M